Evidence map›Paper›PMID 27785022›Full record

ArticleInternational journal of nanomedicine

Cytotoxic effects of ZnO nanoparticles on mouse testicular cells.

Zhe Han, Qi Yan, Wei Ge, Zhi-Guo Liu, Sangiliyandi Gurunathan, Massimo De Felici, Wei Shen, Xi-Feng Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Evaluation of chemical castration by intra-testicular injection of zinc-doped carbon dots in mature rats.Veterinary research forum : an international quarterly journal · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. TiBiology direct · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Effects of iron oxide nanoparticles as TJournal of nanobiotechnology · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Zhe HanCollege of Biological and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, People's Republic of China.
Qi YanCollege of Biological and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, People's Republic of China.
Wei GeKey Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao, People's Republic of China.
Zhi-Guo LiuCollege of Biological and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, People's Republic of China.
Sangiliyandi GurunathanDepartment of Stem Cell and Regenerative Biology, Konkuk University, Seoul, Republic of Korea.
Massimo De FeliciDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
Wei ShenKey Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao, People's Republic of China.
Xi-Feng ZhangCollege of Biological and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, People's Republic of China.
Wuhan Polytechnic University · CNQingdao Agricultural University · CNKonkuk University · KRUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNanoscience and nanotechnology are developing rapidly, and the applications of nanoparticles (NPs) have been found in several fields. At present, NPs are widely used in traditional consumer and industrial products, however, the properties and safety of NPs are still unclear and there are concerns about their potential environmental and health effects. The aim of the present study was to investigate the potential toxicity of ZnO NPs on testicular cells using both in vitro and in vivo systems in a mouse experimental model.

methodsZnO NPs with a crystalline size of 70 nm were characterized with various analytical techniques, including ultraviolet-visible spectroscopy, Fourier transform infrared spectroscopy, X-ray diffraction, transmission electron microscopy, and atomic force microscopy. The cytotoxicity of the ZnO NPs was examined in vitro on Leydig cell and Sertoli cell lines, and in vivo on the testes of CD1 mice injected with single doses of ZnO NPs.

resultsZnO NPs were internalized by Leydig cells and Sertoli cells, and this resulted in cytotoxicity in a time- and dose-dependent manner through the induction of apoptosis. Apoptosis likely occurred as a consequence of DNA damage (detected as γ-H2AX and RAD51 foci) caused by increase in reactive oxygen species associated with loss of mitochondrial membrane potential. In addition, injection of ZnO NPs in male mice caused structural alterations in the seminiferous epithelium and sperm abnormalities.

conclusionThese results demonstrate that ZnO NPs have the potential to induce apoptosis in testicular cells likely through DNA damage caused by reactive oxygen species, with possible adverse consequences for spermatogenesis and therefore, male fertility. This suggests that evaluating the potential impacts of engineered NPs is essential prior to their mass production, to address both the environmental and human health concerns and also to develop sustainable and safer nanomaterials.

Indexed as

AnimalsApoptosisCells, CulturedDNA DamageHumansLeydig CellsMaleMetal NanoparticlesMiceMicroscopy, Atomic ForceMicroscopy, Electron, TransmissionNanotechnologyReactive Oxygen SpeciesSertoli CellsSpectroscopy, Fourier Transform InfraredX-Ray DiffractionReactive Oxygen SpeciesZinc OxideLeydig cellsmiceSertoli cellsZnO nanoparticle

Identifiers

PMID27785022
PMCPMC5066861
OpenAlexW2530784749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.